Generated by AI
Illumina Inc. is a global genomics and life sciences company that develops DNA sequencing and array-based technologies used to analyze genetic variation and biological function. Its products and systems support research, clinical testing, and applied markets across areas such as oncology, inherited and infectious diseases, reproductive health, and molecular diagnostics. Illumina also provides sequencing consumables, instruments, software, and support services that help laboratories generate, interpret, and manage genomic data. The company serves customers including academic institutions, genomic research centers, hospitals, pharmaceutical and biotechnology companies, and clinical laboratories. Headquartered in San Diego, California, and founded in 1998, Illumina plays a central role in making genomic analysis more widely accessible for research and healthcare applications.
Website5200 Illumina Way
San Diego, CA, 92122
United States
The latest articles about ILMN.
Summary of Oct 30's posts. Generated by AI.
Summary of Oct 29's posts. Generated by AI.
Summary of Aug 12's posts. Generated by AI.
Summary of Oct 30's posts. Generated by AI.
Investors talking about ILMN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.